Cancer is the malignant disease that severely threatens human health and the incidence and mortality are rapidly growing worldwide.1 Aberrant activation of the NF-κB signalling pathway has been observed in many human cancers,22 making it a promising therapy target for tumour. This evidence concerns the gene NFKB1 and cancer.